Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 12, 2026
Protocol for a multinational, investigator-initiated, parallel group, randomised, double-blind, placebo-controlled phase 3b superiority trial assessing the effect of dupilumab on inducing clinical remission outcomes in at-risk type-2 inflammatory asthma (HOTHOT)Simon Couillard, Nayia Petousi, Sanjay Ramakrishnan, et al.Microbiology Resource Announcements|January 18, 2024
Genome sequence of PSonyx, a singleton bacteriophage infecting Corynebacterium glutamicumOmbeline Rossier, Cécile Labarre, Anne Lopes, et al.The Journal of Allergy and Clinical Immunology. in Practice|January 27, 2024
Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-Asthma BiologicsArnaud Bourdin, Guy Brusselle, Simon Couillard, et al.Thorax|April 21, 2026
Association of blood eosinophils and exhaled nitric oxide with exacerbations in patients with asthma, COPD and asthma+COPD: the NOVELTY studySusan Muiser, Hana Müllerová, Laura Belton, et al.BMJ Open Respiratory Research|November 28, 2025
Integrating blood eosinophils and exhaled nitric oxide (FeNO) in asthma diagnostic pathways for adults and children: the PROPULSION SANTÉ observational study with translational sub-studies (DIVE, DIVE2)-protocolsMorgane Gronnier, Laurence Désy, Lauranne Pouliot, et al.Allergy|May 17, 2022
Airway remodelling rather than cellular infiltration characterizes both type2 cytokine biomarker-high and -low severe asthmaLatifa Khalfaoui, Fiona A Symon, Simon Couillard, et al.Chest|February 1, 2026
Sex does not modify prediction of asthma attacks by clinical risk factors and Type-2 biomarkersSebastian Riemann, Fleur L Meulmeester, Samuel Mailhot-Larouche, et al.The Lancet. Respiratory Medicine|April 11, 2025
Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trialsFleur L Meulmeester, Samuel Mailhot-Larouche, Carlos Celis-Preciado, et al.BMJ Open|March 6, 2025
The Canadian Lung Outcomes in Users of Vaping Devices (CLOUD) Study: protocol for a prospective, observational cohort studyPaloma Burns, Rachel L Eddy, Xuan Li, et al.American Journal of Respiratory and Critical Care Medicine|May 18, 2025
Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with BiologicsMohsen Sadatsafavi, Trung N Tran, Ghislaine Scelo, et al.Pageof 5